Bouma M - Search Results

1

Compatibility and stability of the investigational polypeptide marine anticancer agent kahalalide F in infusion devices.

Nuijen B, Bouma M, Manada C, Jimeno JM, Lazaro LL, Bult A, Beijnen JH. Nuijen B, et al. Among authors: bouma m. Invest New Drugs. 2001;19(4):273-81. doi: 10.1023/a:1010641207791. Invest New Drugs. 2001. PMID: 11561686

2

Compatibility and stability of aplidine, a novel marine-derived depsipeptide antitumor agent, in infusion devices, and its hemolytic and precipitation potential upon i.v. administration.

Nuijen B, Bouma M, Henrar RE, Manada C, Bult A, Beijnen JH. Nuijen B, et al. Among authors: bouma m. Anticancer Drugs. 1999 Nov;10(10):879-87. doi: 10.1097/00001813-199911000-00003. Anticancer Drugs. 1999. PMID: 10630355

3

Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidine.

Nuijen B, Bouma M, Henrar RE, Floriano P, Jimeno JM, Talsma H, Kettenes-van den Bosch JJ, Heck AJ, Bult A, Beijnen JH. Nuijen B, et al. Among authors: bouma m. PDA J Pharm Sci Technol. 2000 May-Jun;54(3):193-208. PDA J Pharm Sci Technol. 2000. PMID: 10927911

4

Pharmaceutical development of anticancer agents derived from marine sources.

Nuijen B, Bouma M, Manada C, Jimeno JM, Schellens JH, Bult A, Beijnen JH. Nuijen B, et al. Among authors: bouma m. Anticancer Drugs. 2000 Nov;11(10):793-811. doi: 10.1097/00001813-200011000-00003. Anticancer Drugs. 2000. PMID: 11142687 Review.

5

Progress in the development of alternative pharmaceutical formulations of taxanes.

Nuijen B, Bouma M, Schellens JH, Beijnen JH. Nuijen B, et al. Among authors: bouma m. Invest New Drugs. 2001 May;19(2):143-53. doi: 10.1023/a:1010682916808. Invest New Drugs. 2001. PMID: 11392448 Review.

6

In vitro hemolysis and buffer capacity studies with the novel marine anticancer agent kahalalide F and its reconstitution vehicle cremophor EL/ethanol.

Nuijen B, Bouma M, Manada C, Jimeno JM, Bult A, Beijnen JH. Nuijen B, et al. Among authors: bouma m. PDA J Pharm Sci Technol. 2001 Jul-Aug;55(4):223-9. PDA J Pharm Sci Technol. 2001. PMID: 11505554

7

Development of a lyophilized parenteral pharmaceutical formulation of the investigational polypeptide marine anticancer agent kahalalide F.

Nuijen B, Bouma M, Talsma H, Manada C, Jimeno JM, Lopez-Lazaro L, Bult A, Beijnen JH. Nuijen B, et al. Among authors: bouma m. Drug Dev Ind Pharm. 2001 Sep;27(8):767-80. doi: 10.1081/ddc-100107240. Drug Dev Ind Pharm. 2001. PMID: 11699828

8

Stability and compatibility of the investigational polymer-conjugated platinum anticancer agent AP 5280 in infusion systems and its hemolytic potential.

Bouma M, Nuijen B, Stewart DR, Rice JR, Jansen BA, Reedijk J, Bult A, Beijnen JH. Bouma M, et al. Anticancer Drugs. 2002 Oct;13(9):915-24. doi: 10.1097/00001813-200210000-00003. Anticancer Drugs. 2002. PMID: 12394254

9

Photostability profiles of the experimental antimetastatic ruthenium complex NAMI-A.

Bouma M, Nuijen B, Jansen MT, Sava G, Bult A, Beijnen JH. Bouma M, et al. J Pharm Biomed Anal. 2002 Nov 7;30(4):1287-96. doi: 10.1016/s0731-7085(02)00458-2. J Pharm Biomed Anal. 2002. PMID: 12408919

10

A kinetic study of the chemical stability of the antimetastatic ruthenium complex NAMI-A.

Bouma M, Nuijen B, Jansen MT, Sava G, Flaibani A, Bult A, Beijnen JH. Bouma M, et al. Int J Pharm. 2002 Nov 6;248(1-2):239-46. doi: 10.1016/s0378-5173(02)00460-x. Int J Pharm. 2002. PMID: 12429477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters